Verve Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ALPHABET INC. | 08/01/2025 | 12.17 M | $136.65 M | -1.46% | 13.70% |
| BLACKROCK, INC. | 08/12/2025 | 7.36 M | $82.62 M | -6.62% | 8.29% |
| PENTWATER CAPITAL MANAGEMENT LP | 08/14/2025 | 6.72 M | $75.47 M | 100.00% | 7.57% |
| VANGUARD GROUP INC | 08/11/2025 | 4.19 M | $47.07 M | 5.99% | 4.72% |
| CASDIN CAPITAL, LLC | 08/14/2025 | 4.10 M | $45.99 M | 2.50% | 4.61% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2025 | 3.61 M | $40.56 M | 296.05% | 4.07% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 08/05/2025 | 2.74 M | $30.75 M | 100.00% | 3.08% |
| STATE STREET CORP | 08/14/2025 | 2.63 M | $29.50 M | -15.02% | 2.96% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/18/2025 | 2.10 M | $23.53 M | 100.00% | 2.36% |
| ARCH VENTURE MANAGEMENT, LLC | 08/14/2025 | 2.01 M | $22.56 M | 0.00% | 2.26% |
| UBS GROUP AG | 08/14/2025 | 1.87 M | $21.01 M | 1,319.50% | 2.11% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/18/2025 | 1.75 M | $19.63 M | 100.00% | 1.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 1.70 M | $19.14 M | 1.31% | 1.92% |
| BAKER BROS. ADVISORS LP | 08/14/2025 | 1.69 M | $19.00 M | 0.00% | 1.91% |
| NUVEEN, LLC | 08/12/2025 | 1.61 M | $18.10 M | 21.68% | 1.82% |
| JPMORGAN CHASE & CO | 08/12/2025 | 1.14 M | $12.82 M | 261.16% | 1.29% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 1.05 M | $11.76 M | 479.42% | 1.18% |
| DIMENSIONAL FUND ADVISORS LP | 08/12/2025 | 817.53 K | $9.18 M | 83.92% | 0.92% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2025 | 812.36 K | $9.12 M | 114.01% | 0.91% |
| REDMILE GROUP, LLC | 08/14/2025 | 740.26 K | $8.31 M | -38.68% | 0.83% |
| NORDEA INVESTMENT MANAGEMENT AB | 07/29/2025 | 675.85 K | $7.62 M | 100.00% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 592.44 K | $6.65 M | 4.27% | 0.67% |
| NORTHERN TRUST CORP | 08/13/2025 | 588.83 K | $6.61 M | -5.23% | 0.66% |
| BNP PARIBAS ARBITRAGE, SNC | 08/14/2025 | 566.20 K | $6.36 M | 9,951.55% | 0.64% |
| WEISS ASSET MANAGEMENT LP | 08/14/2025 | 538.42 K | $6.05 M | 100.00% | 0.61% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 485.80 K | $5.46 M | -70.25% | 0.55% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 469.02 K | $5.27 M | 100.00% | 0.53% |
| TWO SIGMA ADVISERS, LP | 08/14/2025 | 381.30 K | $4.28 M | 119.39% | 0.43% |
| OMERS ADMINISTRATION CORP | 08/13/2025 | 371.20 K | $4.17 M | 100.00% | 0.42% |
| WATER ISLAND CAPITAL LLC | 08/14/2025 | 335.59 K | $3.77 M | 100.00% | 0.38% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/14/2025 | 331.44 K | $3.72 M | 100.00% | 0.37% |
| GABELLI & CO INVESTMENT ADVISERS, INC. | 08/13/2025 | 302.40 K | $3.40 M | 100.00% | 0.34% |
| BARCLAYS PLC | 08/14/2025 | 301.60 K | $3.39 M | 61.31% | 0.34% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2025 | 298.69 K | $3.35 M | 22.32% | 0.34% |
| GABELLI FUNDS LLC | 08/13/2025 | 267.52 K | $3.00 M | 100.00% | 0.30% |
| TREXQUANT INVESTMENT LP | 08/12/2025 | 229.78 K | $2.58 M | -60.95% | 0.26% |
| CSS LLC/IL | 08/14/2025 | 223.60 K | $2.51 M | 100.00% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 08/05/2025 | 220.79 K | $2.48 M | -1.89% | 0.25% |
| AQR ARBITRAGE LLC | 08/14/2025 | 208.70 K | $2.34 M | 100.00% | 0.24% |
| JANE STREET GROUP, LLC | 08/14/2025 | 198.66 K | $2.23 M | 97.21% | 0.22% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2025 | 183.61 K | $2.06 M | 37.47% | 0.21% |
| CITIGROUP INC | 08/11/2025 | 176.56 K | $1.98 M | 25.33% | 0.20% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2025 | 176.28 K | $1.98 M | -93.97% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 170.20 K | $1.91 M | 134.44% | 0.19% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2025 | 169.17 K | $1.90 M | 12.12% | 0.19% |
| INVESCO LTD. | 08/13/2025 | 143.45 K | $1.61 M | 68.05% | 0.16% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 138.22 K | $1.55 M | -93.45% | 0.16% |
| CHICAGO CAPITAL MANAGEMENT, LLC | 08/07/2025 | 125.38 K | $1.41 M | 100.00% | 0.14% |
| FIDUCIARY TRUST CO | 08/14/2025 | 120.00 K | $1.35 M | 50.00% | 0.14% |
| JEFFERIES FINANCIAL GROUP INC. | 08/12/2025 | 116.90 K | $1.31 M | 100.00% | 0.13% |
Verve Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 175 institutional investors and hedge funds held shares of Verve Therapeutics, Inc.. The most heavily invested institutionals were:
UBS Group AG: 0
ProShare Advisors LLC: 0
INTECH INVESTMENT MANAGEMENT LLC: 0
XTX Topco Ltd: 0
OMERS ADMINISTRATION Corp: 0
WELLS FARGO & COMPANY/MN: 0
79.30% of Verve Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.28 M shares in the last 24 months. This purchase volume represents approximately $92.18 M in transactions.